Search research articles
Contact Us
Filters
Showing results (511-520 of 535) with videos related to
Page
of 54
Sort By:
ESMO Open
|
July 13, 2023
Neoadjuvant treatment does not influence PD-L1 expression in stage III non-small-cell lung cancer: a retrospective analysis of tumor samples from the trials SAKK 16/96, 16/00, 16/01, and 16/14
D König, S Savic Prince, S Hayoz, et al.
The Journal of Clinical Investigation
|
May 3, 2017
Disruption of lineage specification in adult pulmonary mesenchymal progenitor cells promotes microvascular dysfunction
Christa F Gaskill, Erica J Carrier, Jonathan A Kropski, et al.
Biorxiv : the Preprint Server for Biology
|
March 30, 2023
Targeted engagement of β-catenin-Ikaros complexes in refractory B-cell malignancies
Kadriye Nehir Cosgun, Huda Jumaa, Mark E Robinson, et al.
Nature Cancer
|
January 8, 2026
Targeting β-catenin degradation with GSK3β inhibitors induces cell death in acute lymphoblastic leukemia
Kadriye Nehir Cosgun, Huda Jumaa, Mark E Robinson, et al.
Nature Medicine
|
September 12, 2017
A mouse model for embryonal tumors with multilayered rosettes uncovers the therapeutic potential of Sonic-hedgehog inhibitors
Julia E Neumann, Annika K Wefers, Sander Lambo, et al.
Cancer
|
May 5, 2017
Hispanics have the lowest stem cell transplant utilization rate for autologous hematopoietic cell transplantation for multiple myeloma in the United States: A CIBMTR report
Jeffrey R Schriber, Parameswaran N Hari, Kwang Woo Ahn, et al.
Immunity
|
May 5, 2021
Uncoupling of macrophage inflammation from self-renewal modulates host recovery from respiratory viral infection
Bibo Zhu, Yue Wu, Su Huang, et al.
Cell
|
June 19, 2018
Mitophagy in Intestinal Epithelial Cells Triggers Adaptive Immunity during Tumorigenesis
Paul K Ziegler, Julia Bollrath, Charles K Pallangyo, et al.
JAMA Oncology
|
July 17, 2025
Risk Factors for COVID-19-Related Hospitalization and Death in Patients With Cancer: The National Cancer Institute COVID-19 in Cancer Patients Study (NCCAPS)
Brian I Rini, Ana F Best, Mel D Bowman, et al.
Journal of Hematology & Oncology
|
August 22, 2020
Daratumumab, bortezomib, and dexamethasone in relapsed or refractory multiple myeloma: subgroup analysis of CASTOR based on cytogenetic risk
Katja Weisel, Andrew Spencer, Suzanne Lentzsch, et al.
Page
of 54
Search research articles
Search
Showing results (511-520 of 535) with videos related to
Sort By:
Page
of 54
ESMO Open
|
July 13, 2023
Neoadjuvant treatment does not influence PD-L1 expression in stage III non-small-cell lung cancer: a retrospective analysis of tumor samples from the trials SAKK 16/96, 16/00, 16/01, and 16/14
D König, S Savic Prince, S Hayoz, et al.
The Journal of Clinical Investigation
|
May 3, 2017
Disruption of lineage specification in adult pulmonary mesenchymal progenitor cells promotes microvascular dysfunction
Christa F Gaskill, Erica J Carrier, Jonathan A Kropski, et al.
Biorxiv : the Preprint Server for Biology
|
March 30, 2023
Targeted engagement of β-catenin-Ikaros complexes in refractory B-cell malignancies
Kadriye Nehir Cosgun, Huda Jumaa, Mark E Robinson, et al.
Nature Cancer
|
January 8, 2026
Targeting β-catenin degradation with GSK3β inhibitors induces cell death in acute lymphoblastic leukemia
Kadriye Nehir Cosgun, Huda Jumaa, Mark E Robinson, et al.
Nature Medicine
|
September 12, 2017
A mouse model for embryonal tumors with multilayered rosettes uncovers the therapeutic potential of Sonic-hedgehog inhibitors
Julia E Neumann, Annika K Wefers, Sander Lambo, et al.
Cancer
|
May 5, 2017
Hispanics have the lowest stem cell transplant utilization rate for autologous hematopoietic cell transplantation for multiple myeloma in the United States: A CIBMTR report
Jeffrey R Schriber, Parameswaran N Hari, Kwang Woo Ahn, et al.
Immunity
|
May 5, 2021
Uncoupling of macrophage inflammation from self-renewal modulates host recovery from respiratory viral infection
Bibo Zhu, Yue Wu, Su Huang, et al.
Cell
|
June 19, 2018
Mitophagy in Intestinal Epithelial Cells Triggers Adaptive Immunity during Tumorigenesis
Paul K Ziegler, Julia Bollrath, Charles K Pallangyo, et al.
JAMA Oncology
|
July 17, 2025
Risk Factors for COVID-19-Related Hospitalization and Death in Patients With Cancer: The National Cancer Institute COVID-19 in Cancer Patients Study (NCCAPS)
Brian I Rini, Ana F Best, Mel D Bowman, et al.
Journal of Hematology & Oncology
|
August 22, 2020
Daratumumab, bortezomib, and dexamethasone in relapsed or refractory multiple myeloma: subgroup analysis of CASTOR based on cytogenetic risk
Katja Weisel, Andrew Spencer, Suzanne Lentzsch, et al.
Page
of 54